Charalampos Papagoras

Charalampos Papagoras

Auto-generated profile, based on publicly available information

Charalampos Papagoras

First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
PSPanagiotis Skendros
Panagiotis Skendros
AMAlexandros Mitsios
Alexandros Mitsios
ACAkrivi Chrysanthopoulou
Akrivi Chrysanthopoulou
DMDimitrios C. Mastellos
Dimitrios C. Mastellos
SMSimeon Metallidis
Simeon Metallidis
KRKonstantinos Ritis
Konstantinos Ritis
Emerging data indicate that complement and neutrophils contribute to the maladaptive immune response that fuels hyperinflammation and thrombotic microangiopathy, thereby increasing coronavirus 2019 (COVID-19) mortality. Here, we investigated how complement interacts with the platelet/neutrophil extracellular traps (NETs)/thrombin axis, using COVID-19 specimens, cell-based inhibition studies, and NET/human aortic endothelial cell (HAEC) cocultures. Increased plasma levels of NETs, tissue factor (TF) activity, and sC5b-9 were detected in patients. Neutrophils of patients yielded high TF expression and released NETs carrying active TF. Treatment of control neutrophils with COVID-19 platelet-rich plasma generated TF-bearing NETs that induced thrombotic activity of HAECs. Thrombin or NETosis inhibition or C5aR1 blockade attenuated platelet-mediated NET-driven thrombogenicity. COVID-19 serum induced complement activation in vitro, consistent with high complement activity in clinical samples. Complement C3 inhibition with compstatin Cp40 disrupted TF expression in neutrophils. In conclusion, we provide a mechanistic basis for a pivotal role of complement and NETs in COVID-19 immunothrombosis. This study supports strategies against severe acute respiratory syndrome coronavirus 2 that exploit complement or NETosis inhibition.

2 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SAStella Arelaki
Stella Arelaki
AAAthanasios Arampatzioglou
Athanasios Arampatzioglou
KKKonstantinos Kambas
Konstantinos Kambas
CPCharalampos Papagoras
Charalampos Papagoras
PMParaskevi Miltiades
Paraskevi Miltiades
KRKonstantinos Ritis
Konstantinos Ritis
The role of neutrophils in tumour biology is largely unresolved. Recently, independent studies indicated either neutrophil extracellular traps (NETs) or Tissue Factor (TF) involvement in cancer biology and associated thrombosis. However, their individual or combined role in colonic adenocarcinoma is still unexplored. Colectomy tissue specimens and variable number of draining lymph nodes were obtained from ten patients with adenocarcinoma of the colon. NETs deposition and neutrophil presence as well as TF expression were examined by immunostaining. The effect of NETs on cancer cell growth was studied in in vitro co-cultures of Caco-2 cell line and acute myeloid leukemia primary cells. Proliferation and apoptosis/necrosis of cancer cells were analyzed by flow cytometry. TF-bearing NETs and neutrophil localization were prominent in tumour sections and the respective metastatic lymph nodes. Interestingly, neutrophil infiltration and NETs concentration were gradually reduced from the tumour mass to the distal margin. The in vitro-generated NETs impeded growth of cancer cell cultures by inducing apoptosis and/or inhibiting proliferation. These data support further the role of neutrophils and NETs in cancer biology. We also suggest their involvement on cancer cell growth.

1 March 2019 in Mediterranean Journal of Rheumatology
Verified
Journal Article
Open access
CMChristina Misidou
Christina Misidou
CPCharalampos Papagoras
Charalampos Papagoras
Complex regional pain syndrome (CRPS) is a perplexing painful syndrome of the extremities usually following a harmful event. It is distinguished in two types, mainly depending on the presence of nerve injury. Although its prevalence may vary depending on social and ethnic factors, middle-aged women seem to suffer most often and the upper limb is the most commonly affected extremity. Apart from pain, which is the dominating feature, the clinical picture unfolds across several domains: sensory, motor, autonomic and trophic. This syndrome develops in two phases, the acute (warm) phase, with the classic symptoms of inflammation, and the chronic (cold) phase, often characterized by trophic changes of the soft tissues and even bones. Although the syndrome has been studied for over two decades, no imaging or laboratory test has been established for the diagnosis and recently proposed diagnostic criteria have not yet been validated and are only occasionally applied. Its pathophysiology is still quite obscure, although the most likely mechanisms involve the classic and neurogenic paths of inflammation mediated by cytokines and neuropeptides, intertwined with changes of the autonomic and central nervous system, psychological mechanisms and, perhaps, autoimmunity. Although plenty of treatment modalities have been tried, none has been proven unequivocally efficacious. Apart from information and education, which should be offered to all patients, the most effective pharmacological treatments seem to be bisphosphonates, glucocorticoids and vasoactive mediators, while physical therapy and rehabilitation therapy also make part of the treatment.

19 December 2020 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CPCharalampos Papagoras
Charalampos Papagoras
ACAkrivi Chrysanthopoulou
Akrivi Chrysanthopoulou
AMAlexandros Mitsios
Alexandros Mitsios
MNMaria Ntinopoulou
Maria Ntinopoulou
VTVictoria Tsironidou
Victoria Tsironidou
KRKonstantinos Ritis
Konstantinos Ritis

1 November 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
PSPanagiotis Skendros
Panagiotis Skendros
ACAkrivi Chrysanthopoulou
Akrivi Chrysanthopoulou
FRFrançois Rousset
François Rousset
KKKonstantinos Kambas
Konstantinos Kambas
AAAthanasios Arampatzioglou
Athanasios Arampatzioglou
KRKonstantinos Ritis
Konstantinos Ritis

12 October 2016 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PSPanagiotis Skendros
Panagiotis Skendros
CPC. Papagoras
C. Papagoras
ILI. Lefaki
I. Lefaki
AGA. Giatromanolaki
A. Giatromanolaki
IKI. Kotsianidis
I. Kotsianidis
KRK. Ritis
K. Ritis